Literature DB >> 20009024

Effects of fructosamine-3-kinase deficiency on function and survival of mouse pancreatic islets after prolonged culture in high glucose or ribose concentrations.

S M A Pascal1, M Veiga-da-Cunha, P Gilon, E Van Schaftingen, J C Jonas.   

Abstract

Due to their high glucose permeability, insulin-secreting pancreatic beta-cells likely undergo strong intracellular protein glycation at high glucose concentrations. They may, however, be partly protected from the glucotoxic alterations of their survival and function by fructosamine-3-kinase (FN3K), a ubiquitous enzyme that initiates deglycation of intracellular proteins. To test that hypothesis, we cultured pancreatic islets from Fn3k-knockout (Fn3k(-/-)) mice and their wild-type (WT) littermates for 1-3 wk in the presence of 10 or 30 mmol/l glucose (G10 or G30, respectively) and measured protein glycation, apoptosis, preproinsulin gene expression, and Ca(2+) and insulin secretory responses to acute glucose stimulation. The more potent glycating agent d-ribose (25 mmol/l) was used as positive control for protein glycation. In WT islets, a 1-wk culture in G30 significantly increased the amount of soluble intracellular protein-bound fructose-epsilon-lysines and the glucose sensitivity of beta-cells for changes in Ca(2+) and insulin secretion, whereas it decreased the islet insulin content. After 3 wk, culture in G30 also strongly decreased beta-cell glucose responsiveness and preproinsulin mRNA levels, whereas it increased islet cell apoptosis. Although protein-bound fructose-epsilon-lysines were more abundant in Fn3k(-/-) vs. WT islets, islet cell survival and function and their glucotoxic alterations were almost identical in both types of islets, except for a lower level of apoptosis in Fn3k(-/-) islets cultured for 3 wk in G30. In comparison, d-ribose (1 wk) similarly decreased preproinsulin expression and beta-cell glucose responsiveness in both types of islets, whereas it increased apoptosis to a larger extent in Fn3k(-/-) vs. WT islets. We conclude that, despite its ability to reduce the glycation of intracellular islet proteins, FN3K is neither required for the maintenance of beta-cell survival and function under control conditions nor involved in protection against beta-cell glucotoxicity. The latter, therefore, occurs independently from the associated increase in the level of intracellular fructose-epsilon-lysines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20009024     DOI: 10.1152/ajpendo.00503.2009

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  6 in total

1.  Mitochondrial oxidative stress contributes differently to rat pancreatic islet cell apoptosis and insulin secretory defects after prolonged culture in a low non-stimulating glucose concentration.

Authors:  L P Roma; S M Pascal; J Duprez; J-C Jonas
Journal:  Diabetologia       Date:  2012-05-29       Impact factor: 10.122

Review 2.  Impaired proteostasis: role in the pathogenesis of diabetes mellitus.

Authors:  Stéphane Jaisson; Philippe Gillery
Journal:  Diabetologia       Date:  2014-05-11       Impact factor: 10.122

3.  Can Tea Extracts Exert a Protective Effect Against Diabetes by Reducing Oxidative Stress and Decreasing Glucotoxicity in Pancreatic β-Cells?

Authors:  Heeyoung Chae; Patrick Gilon
Journal:  Diabetes Metab J       Date:  2015-02       Impact factor: 5.376

Review 4.  The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers.

Authors:  Narasimha M Beeraka; Venugopal R Bovilla; Shalini H Doreswamy; Sujatha Puttalingaiah; Asha Srinivasan; SubbaRao V Madhunapantula
Journal:  Cancers (Basel)       Date:  2021-01-14       Impact factor: 6.639

5.  Evaluation of Fructosamine 3-kinase and Glyoxalase 1 activity in normal and breast cancer tissues.

Authors:  Tooba Yousefi; Abdol Rahim Gholizadeh Pasha; Ghodsieh Kamrani; Ailin Ebrahimzadeh; Ali Zahedian; Karimollah Hajian-Tilaki; Mohammad Aghajani; Durdi Qujeq
Journal:  Biomedicine (Taipei)       Date:  2021-09-01

Review 6.  Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus.

Authors:  Jing Yong; James D Johnson; Peter Arvan; Jaeseok Han; Randal J Kaufman
Journal:  Nat Rev Endocrinol       Date:  2021-06-23       Impact factor: 43.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.